Mogrify Enters Research Collaboration with the MRC Laboratory of Molecular Biology

Business Wire

Published

CAMBRIDGE, England--(BUSINESS WIRE)--Mogrify Limited (Mogrify®), a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, and the MRC Laboratory of Molecular Biology (LMB), a world-class research laboratory dedicated to understanding important biological processes at the molecular level, today announced an exploratory research collaboration. The project aims to develop novel protein expression systems by leveraging rece

Full Article